Marcos Ramos-Benitez to Middle Aged
This is a "connection" page, showing publications Marcos Ramos-Benitez has written about Middle Aged.
Connection Strength
0.221
-
Caro-Rivera LM, Malavez-Cajigas S, Lacourt-Ventura M, Rivera-Torres AP, Marcano-Jim?nez DE, L?pez-Colon P, Mu?iz-Hern?ndez J, Rivera-Jim?nez E, Egozcue-Dionisi M, Rom?n-Carlo R, De Jes?s-Rojas W, Ramos-Ben?tez MJ. Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1. Orphanet J Rare Dis. 2025 May 12; 20(1):226.
Score: 0.080
-
Ramos-Benitez MJ, Miao R, Rivera-Torres AP, Lacourt-Ventura M, Malavez-Cajigas SJ, Tian X, Teague HL, De Jesus-Rojas W, Reger R, Suffredini AF, King C, Nathan SD, Childs RW, Strich JR. Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19. Crit Care Explor. 2025 Apr 01; 7(4):e1252.
Score: 0.080
-
Arif M, Basu A, Zuo BLG, Zuo MXG, O'Brien KJ, Pommerolle L, Caro-Rivera LM, De Jesus-Rojas W, Ramos-Benitez MJ, Behan M, Introne WJ, Frost G, Moaddel R, Gahl WA, Malicdan MCV, Gochuico BR, Cinar R. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2026 Jan 01; 74(1):80-93.
Score: 0.021
-
Rom?n-R?os G, Rosario-Ortiz G, Ramos-Benitez MJ, Mosquera RA, De Jes?s-Rojas W. RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia. Adv Respir Med. 2025 Aug 02; 93(4).
Score: 0.020
-
De Jes?s-Rojas W, Reyes-Pe?a L, Mu?iz-Hernandez J, Mena-Ventura R, Camareno-Soto G, Rosario-Ortiz G, Ramos-Benitez MJ, Egozcue-Dionisi M, Rivera-Jimenez E, Rom?n-Carlo R. Application of Forced Oscillation Technique in Assessing Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. Adv Respir Med. 2024 Oct 24; 92(6):444-451.
Score: 0.019